Charles A Flentge

This inventor holds 14 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Knopp Biosciences, LLC, Biohaven Therapeutics Ltd.. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles A Flentge. Retrieved from https://idiyas.com/inventor/charles-a-flentge-5jcx7bf6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 14 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 7.5

ph-index = 5

Forward Citations = 51(Granted Patents)

Company Filing History:

9 out of 27

Knopp Biosciences, LLC

patents

4 out of 33

Biohaven Therapeutics Ltd.

patents

where one patent can have more than one assignee

Years Active: 2016-2026

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12747237 - Pyrazolyl compounds as KV7 channel activators (2026-09-29),

2. 12351559 - Benzoimidazol benzomidazol-1,2-yl amides as Kv7 channel activators (2025-07-08),

3. 12286408 - KV7 channel activators compositions and methods of use (2025-04-29),

4. 11834418 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2023-12-05),

5. 11724990 - Kv7 channel activators compositions and methods of use (2023-08-15),

6. 11261162 - KV7 channel activators compositions and methods of use (2022-03-01),

7. 10906877 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2021-02-02),

8. 10851067 - Kv7 channel activators compositions and methods of use (2020-12-01),

9. 10526328 - Imidazo[4,5-b]pyridin-2-yl amides as Kv7 channel activators (2020-01-07),

10. 10385025 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2019-08-20),

11. 10106536 - Imidazo(4,5-B) pyridin-2-yl amides as KV7 channel activators (2018-10-23),

12. 9914708 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2018-03-13),

13. 9650376 - [object Object] (2017-05-16),

14. 9481653 - Benzoimidazol-1,2-yl amides as Kv7 channel activators (2016-11-01),

Title: The Innovative Journey of Charles A. Flentge

Introduction: Charles A. Flentge, a pioneering inventor hailing from Mars, PA (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: Charles A. Flentge holds several patents in various fields, including robotics, artificial intelligence, and renewable energy technologies.

Career Highlights: With a career spanning over two decades, Charles A. Flentge has worked with leading tech companies, research institutions, and universities to develop cutting-edge solutions that have revolutionized industries.

Collaborations: Throughout his career, Charles A. Flentge has collaborated with top engineers, scientists, and researchers to bring his innovative ideas to life. His collaborative spirit has led to the successful implementation of several game-changing projects.

Conclusion: Charles A. Flentge's passion for innovation and his relentless pursuit of excellence have solidified his position as a visionary inventor in the realm of technology. His contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.